Are you Dr. Kumar?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 88 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2401 W Belvedere Ave
Baltimore, MD 21215Phone+1 410-601-4710Fax+1 410-601-8526
Summary
- Dr. Pallavi Kumar, MD is an oncologist in Baltimore, Maryland. She is currently licensed to practice medicine in Maryland. She is affiliated with MedStar Harbor Hospital and MedStar Franklin Square Medical Center.
Education & Training
- Johns Hopkins UniversityResidency, Internal Medicine, 1998 - 2001
- East Tennessee State University James H. Quillen College of MedicineClass of 1998
Certifications & Licensure
- MD State Medical License 2001 - 2026
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2012
Clinical Trials
- Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma Start of enrollment: 2001 Jan 01
- Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Start of enrollment: 2008 Feb 25
- Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer Start of enrollment: 2009 Sep 14
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsMulticenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence.Craig L. Slingluff, Karl D. Lewis, Robert H.I. Andtbacka, John R. Hyngstrom, Mohammed M. Milhem
Journal for Immunotherapy of Cancer. 2021-10-01 - 2 citationsHypercalcemia and diffuse osteolytic lesions in a 45-year-old patient with myeloid sarcoma with megakaryocytic differentiationAditya Goud, Abdelhai Abdelqader, Chanukya Dahagam, Ramez Jabaji, Pallavi Kumar
Journal of Community Hospital Internal Medicine Perspectives. 2016-04-25 - 1 citationsUpdate on Kaposi's Sarcoma: A Gammaherpesvirus- induced Malignancy.Pallavi Kumar, Richard F. Little, Robert Yarchoan
Current Infectious Disease Reports. 2003-02-01
Professional Memberships
- Member